FOXP3 and inflammatory bowel disease: Cai et al. described utilizing exosomes that were derived from TGF-β1 gene-modified BM-DCs to induce Foxp3+ Treg cells and decrease the proportion of Th17 cells in a mouse model of inflammatory bowel disease [31].